Dianthus Therapeutics, Inc. (DNTH) vs Erasca, Inc. (ERAS)
Dianthus Therapeutics, Inc. and Erasca, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. and Erasca, Inc. are of similar size ($5.1B and $5.1B). Erasca, Inc. has the higher net margin (0.00% vs −10,097.0%) and the lower return on invested capital (−203.1% vs −47.7%). Across the 13 metrics below, Dianthus Therapeutics, Inc. leads on 8 and Erasca, Inc. on 5.
Valuation
Profitability
| Metric | DNTH | ERAS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (11,441.39%) | 0.00% | 0.00% |
| Net margin | (10,096.95%) | 0.00% | 0.00% |
| Free cash flow margin | (8,177.99%) | 0.00% | 0.00% |
| Return on equity | (26.07%) | (78.25%) | (57.72%) |
| Return on assets | (24.98%) | (65.25%) | (49.22%) |
| Return on invested capital | (47.74%) | (203.13%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack